Press Releases April 21, 2026 08:00 AM

First Watch Restaurant Group, Inc. to Report First Quarter 2026 Financial Results on May 5, 2026

First Watch Restaurant Group to announce Q1 2026 financial results on May 5, 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
FWRG

First Watch Restaurant Group, a leading daytime dining restaurant chain, announced it will release its first quarter 2026 financial results before market open on May 5, 2026, with a subsequent conference call and webcast hosted by the CEO and CFO.

First Watch Restaurant Group, Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
FWRG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • First Watch operates over 630 restaurants in 32 states, focusing on breakfast, brunch, and lunch with a chef-driven, seasonal menu.
  • The company has a strong community presence and has been recognized multiple times for quality and workplace culture.
  • The upcoming earnings release and conference call will provide insights into the company’s financial and operational performance for Q1 2026.

BRADENTON, Fla., April 21, 2026 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced that it plans to release its first quarter 2026 financial results on Tuesday, May 5, 2026, before the market opens.

A conference call and webcast will follow at 8:00 AM ET, hosted by Chris Tomasso, Chief Executive Officer and President, and Mel Hope, Chief Financial Officer.

Interested parties may listen to the conference call via any one of three options:

  • Dial 201-389-0914, which will be answered by an operator
  • Pre-register by entering your information at this Call Me™ link
  • Join the webcast at https://investors.firstwatch.com/news-and-events/events

The webcast will be archived shortly after the call has concluded. For the dial-in and webcast options, the conference call should be accessed at least 10 minutes prior to its scheduled start.

About First Watch
First Watch is the leading Daytime Dining concept serving made-to-order breakfast, brunch and lunch using the freshest ingredients available. Guided by its “Follow the Sun” culinary philosophy, First Watch's chef-driven menu rotates five times a year to feature the highest-quality flavors at their peak, offering elevated executions of classic favorites, fresh juices like the Kale Tonic, and fan favorites such as the Lemon Ricotta Pancakes, Quinoa Power Bowl and signature Million Dollar Bacon. For every kid’s meal served, First Watch proudly donates a portion to organizations and causes making a positive impact in our communities – raising more than $1.7 million to date. A recipient of hundreds of local “Best Breakfast” and “Best Brunch” awards, First Watch was voted 2025’s #1 Best Breakfast by Newsweek’s Readers’ Choice Awards and was also named 2025 and 2024’s #1 Most Loved Workplace® in America by the Best Practice Institute (as seen in The Wall Street Journal), after appearing on the list in 2022 and 2023 as well. With a commitment to quality, hospitality and community, First Watch is redefining Daytime Dining across more than 630 restaurants in 32 states. For more information, visit www.firstwatch.com.

Investor Relations Contact

Steven L. Marotta
941-500-1918
[email protected]

Media Relations Contact:

Jenni Glester
407-864-5823
[email protected]


Risks

  • The financial results could reflect challenges in the casual dining sector impacted by economic factors such as inflation and labor costs.
  • Seasonal menu changes and supply chain issues could affect food costs and inventory management.
  • The restaurant industry faces competition and changing consumer preferences, which could impact future performance.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026